In 2001, Guy Payette had a vision of changing the specialty pharmaceutical market place and he created Innomar—Innovative Market Access. The result of his commitment to helping patients navigate the Canadian healthcare system was the first integrated model for specialty pharmaceutical manufactures. Today, Guy is the president of Innomar Strategies, HealthForward and Cameron Stewart LifeScience and an expert in the Canadian specialty pharmaceutical commercialization journey.
Guy leads the team of over 1,700 associates who are focused on delivering customized commercialization solutions to pharmaceutical, biotech and medical device manufacturers. In 2009, he led the acquisition of Innomar to AmerisourceBergen, further broadening its capabilities and global network. In 2012, he started HealthForward, a company focused on optimizing health outcomes and access to therapy for patients while helping payers and plan sponsors achieve long-term sustainability in their drug plans. Before starting Innomar, Guy spent 12 years with Boehringer Ingelheim in senior sales, market access, marketing, and government relations roles.
With 30 years of experience in the pharmaceutical industry, Guy’s insight on emerging issues in the Canadian healthcare environment provide guidance for policy makers and other industry stakeholders. Throughout his career, Guy has been a champion for improved access to medication for Canadian patients.